Implementing thrombectomy for stroke treatment at a smaller hospital
Establishing Mechanical Thrombectomy at a Limited-volume Stroke Center - Effects on Patient Morbidity and Mortality.
Sorlandet Hospital HF · NCT04942041
This study is testing if using a new stroke treatment called thrombectomy at a smaller hospital can help patients recover better and faster.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Sorlandet Hospital HF (other gov) |
| Locations | 1 site (Kristiansand, Agder) |
| Trial ID | NCT04942041 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on the implementation of mechanical thrombectomy for patients with large vessel occlusion stroke at Sørlandet Hospital, a limited-volume stroke center in Norway. The introduction of this treatment is guided by a simulation-based quality assurance program to address potential quality challenges. The study will monitor timelines, technical and clinical outcomes, and adverse events to assess the impact of this intervention on patient morbidity and mortality. By reducing transfer times to comprehensive centers, the study aims to improve patient outcomes in acute stroke care.
Who should consider this trial
Good fit: Ideal candidates for this study are adult patients diagnosed with large vessel occlusion stroke.
Not a fit: Patients with intracranial hemorrhage, tumors, aneurysms, or vascular malformations in the stroke area, or those who present more than 24 hours after stroke onset may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce morbidity and mortality for stroke patients treated at smaller hospitals.
How similar studies have performed: Other studies have shown that timely thrombectomy can significantly improve outcomes in stroke patients, suggesting that this approach may yield positive results as well.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients * Large vessel occlusion stroke Exclusion Criteria: * Intracranial hemorrhage, tumor, aneurism or vascular malformation i the stroke area * More than 24 hours after stroke onset
Where this trial is running
Kristiansand, Agder
- Sørlandet Hospital Health Trust — Kristiansand, Agder, Norway (RECRUITING)
Study contacts
- Principal investigator: Per Kristian Hyldmo, MD PhD — University of Stavanger, Norway
- Study coordinator: Olav Søvik, MD
- Email: olav.sovik@sshf.no
- Phone: +4741689421
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Stroke, Acute Ischemic, Stroke, Thrombectomy, Simulation, Quality program